Shoulder Innovations (NYSE:SI) Major Shareholder Healthcare Holding B.V. Gilde Sells 99,812 Shares

Shoulder Innovations, Inc. (NYSE:SI) major shareholder Healthcare Holding B.V. Gilde sold 99,812 shares of Shoulder Innovations stock in a transaction dated Tuesday, August 4th. The stock was sold at an average price of $22.77, for a total transaction of $2,272,719.24. Following the transaction, the insider directly owned 2,221,640 shares in the company, valued at $50,586,742.80. This trade represents a 4.30% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Large shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.

Healthcare Holding B.V. Gilde also recently made the following trade(s):

• On Monday, August 3rd, Healthcare Holding B.V. Gilde sold 10,751 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.71, for a total value of $244,155.21.
• On Friday, July 31st, Healthcare Holding B.V. Gilde sold 20,034 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.73, for a total value of $455,372.82.
• On Thursday, July 30th, Healthcare Holding B.V. Gilde sold 28,245 shares of Shoulder Innovations stock. The stock was sold at an average price of $23.36, for a total value of $659,803.20.

Shoulder Innovations Stock Down 0.6%

Shares of NYSE:SI opened at $22.56 on Thursday. The business has a 50-day moving average price of $19.65 and a 200 day moving average price of $15.98. The company has a current ratio of 11.81, a quick ratio of 10.04 and a debt-to-equity ratio of 0.11. The company has a market capitalization of $467.89 million and a price-to-earnings ratio of -0.14. Shoulder Innovations, Inc. has a 12-month low of $10.92 and a 12-month high of $24.59.

Shoulder Innovations (NYSE:SI) last posted its earnings results on Wednesday, May 13th. The company reported ($0.41) EPS for the quarter, beating analysts’ consensus estimates of ($0.44) by $0.03. Shoulder Innovations had a negative net margin of 81.78% and a negative return on equity of 35.11%. The company had revenue of $16.71 million for the quarter. Sell-side analysts expect that Shoulder Innovations, Inc. will post -1.67 EPS for the current year.

Institutional Investors Weigh In On Shoulder Innovations

Several large investors have recently added to or reduced their stakes in the business. Roubaix Capital LLC boosted its position in Shoulder Innovations by 61.9% in the 1st quarter. Roubaix Capital LLC now owns 257,121 shares of the company’s stock valued at $3,736,000 after buying an additional 98,305 shares during the period. Sectoral Asset Management Inc. increased its position in shares of Shoulder Innovations by 14.4% during the fourth quarter. Sectoral Asset Management Inc. now owns 492,435 shares of the company’s stock worth $7,042,000 after acquiring an additional 62,153 shares during the period. KCM Capital Inc acquired a new stake in shares of Shoulder Innovations in the first quarter valued at $509,000. Royal Bank of Canada raised its stake in shares of Shoulder Innovations by 7,046.3% in the first quarter. Royal Bank of Canada now owns 53,883 shares of the company’s stock valued at $783,000 after acquiring an additional 53,129 shares in the last quarter. Finally, Wells Fargo & Company MN boosted its holdings in Shoulder Innovations by 66.3% in the fourth quarter. Wells Fargo & Company MN now owns 5,250 shares of the company’s stock valued at $75,000 after purchasing an additional 2,094 shares during the period.

Analysts Set New Price Targets

Several analysts recently weighed in on SI shares. Piper Sandler reiterated an “overweight” rating and issued a $19.00 target price (up from $18.00) on shares of Shoulder Innovations in a report on Friday, May 8th. Weiss Ratings upgraded Shoulder Innovations from a “sell (d-)” rating to a “sell (d)” rating in a research report on Monday. Finally, UBS Group assumed coverage on Shoulder Innovations in a research note on Tuesday, July 28th. They issued a “buy” rating and a $27.00 price objective for the company. Six equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Shoulder Innovations presently has an average rating of “Moderate Buy” and a consensus target price of $22.00.

Shoulder Innovations Company Profile

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.